Janssen-Cilag Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Janssen-Cilag Limited - overview
Established
1971
Location
High Wycombe, -, UK
Primary Industry
Pharmaceuticals
About
Based in Buckinghamshire, UK, Janssen-Cilag Limited operates as a pharmaceutical company that develops and markets prescription medicines. It offers a range of prescription medicines and vaccines for diseases in therapeutic areas like oncology, immunology, neuroscience, and infectious diseases. It also provides services related to medical education and information for healthcare professionals.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
https://www.janssen.co.uk
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Janssen-Cilag Limited - financials
| Fiscal Year Ended | Dec 31, 2017 | Dec 30, 2018 | Dec 29, 2019 | Dec 29, 2020 | Jan 03, 2021 | Jan 02, 2022 | Jan 01, 2023 |
|---|---|---|---|---|---|---|---|
| Revenue (USD) | 552,543,000 | 621,858,000 | 575,824,000 | - | - | - | - |
| % Revenue Growth (YoY) | - | 12.5% | (7.4%) | - | - | - | - |
| EBITDA (USD) | 48,735,000 | 49,132,000 | 53,925,000 | - | - | - | - |
| Operating Income (USD) | 44,043,000 | 43,719,000 | 48,133,000 | - | - | - | - |
| Operating Margin | 8.0% | 7.0% | 8.4% | - | - | - | - |
| % EBITDA Margin | 8.8% | 7.9% | 9.4% | - | - | - | - |
| NET Income (USD) | 35,316,000 | 38,055,000 | 37,556,000 | - | - | - | - |
| % Net Margin | 6.4% | 6.1% | 6.5% | - | - | - | - |

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.